Withania somnifera(L.)Dunal(WS),or Ashwagandha,is used clinically against arthritis,anxiety and insomnia etc,however,its potential in aquafeeds is largely unexplored.We investigated the stress-alleviation and hepatopr...Withania somnifera(L.)Dunal(WS),or Ashwagandha,is used clinically against arthritis,anxiety and insomnia etc,however,its potential in aquafeeds is largely unexplored.We investigated the stress-alleviation and hepatoprotective mechanisms of dietary WS supplementation in adult female darkbarbel catfish.Fish were fed with WS dietary for 5 weeks,subjected to a physical stressor(saline injection),and sampled.Brain were processed for RNA-seq to identify differentially expressed genes(DEGs)linked to stress;serum were assayed for stress-and immune-related biochemical markers;livers were examined for lipid content(Oil Red O staining)and proliferation(PCNA immunos-taining).Network pharmacology were employed to construct a"compound-target"net-work:The bioactive compounds of WS were retrieved from ChEBI and PCIDB,probable targets predicted via Swiss Target Prediction,and the“WS-ingredient-target”regulatory network was constructed using Cytoscape;key ligand-protein interactions were validated by molecular docking.Findings were replicated in juvenile fish and in SG3 cells challenged with Withanolide A.Physical stress evoked 1451 DEGs in control brains,whereas WS-supplemented reduced this to 397,indicating marked mitigation of the oxid-ative-and immune-stress response.Network pharmacology and molecular docking pre-dicted that 13 bioactive compounds in WS,especially Withanolide A and Withanolide J,can interact with targets such as MAPK8,CRHR1,NR3C2,and IARS1,being associated with stress and liver function regulation respectively.Moreover,it was proved that Withanolide A could significantly modulate stress response in juveniles and enhanced pro-liferation potency of SG3 cells.Intriguingly,in theadult female darkbarbel catfish,dietary WS lowered serum cortisol,glucose,ROS,TNF-α,and IL-6(P<0.05),up-regulated hepatocyte PCNA expression,and allievated stress-induced liver injury.These findings provide novel insights and vital basis for elucidating the mechanisms whereby herbs,including WS act in stress-relief and hepatoprotection in darkbarbel catfish.And provide a framework for advancing traditional Chinese medicine(TCM)applications in aquaculture.展开更多
Aim: To determine the effect of a methanolic extract of Withania somnifera (L.) Dunal roots on sexual competence of male rats. Methods: Male rats were orally administered 3000 mg'kg^1.day^1 of root extract for 7 d...Aim: To determine the effect of a methanolic extract of Withania somnifera (L.) Dunal roots on sexual competence of male rats. Methods: Male rats were orally administered 3000 mg'kg^1.day^1 of root extract for 7 days. Their sexual behaviour was evaluated 7 days prior to treatment, day 3 and 7 of treatment, and day 7, 14 and 30 posttreatment by pairing each male with a receptive female. Results: The root extract induced a marked impairment in libido, sexual performance, sexual vigour, and penile erectile dysfunction. These effects were partly reversible on cessation of treatment. These antimasculine effects are not due to changes in testosterone levels or toxicity but may be attributed to hyperprolactinemic, GABAergic, serotonergic or sedative activities of the extract. Conclusion: Use of W. somnifera roots may be detrimental to male sexual competence. (Asian J Androl 2002 Dec;4: 295-298)展开更多
Stroke management exerts insurmountable societal and economic burden on the patient as well as their caregivers. In the year 2010 alone, the direct and indirect costs of stroke care amounted to 36.5 billion dollars （...Stroke management exerts insurmountable societal and economic burden on the patient as well as their caregivers. In the year 2010 alone, the direct and indirect costs of stroke care amounted to 36.5 billion dollars （Go et al., 2014）. Despite concentrated efforts to develop a safe, effective drug for stroke, we have not discovered one since the introduction of recombinant tissue plasminogen activator （rtPA）--the standalone FDA-approved therapy for stroke. While rtPA is highly effective, it needs to be given within 3-4.5 hours of the onset of stroke symptoms （Zivin, 2009）. This is often complicated by the delay in the commencement of treatment due to preliminary inclusion parameters that are required to be ascertained before rtPA administration.展开更多
Objective:To study the influence of methanolic and aqueous extract of Withania somnifera (W.somnifera) root on the marble-burying behavior of mice a well-accepted model of obsessive compulsive behavior.Methods:Mice we...Objective:To study the influence of methanolic and aqueous extract of Withania somnifera (W.somnifera) root on the marble-burying behavior of mice a well-accepted model of obsessive compulsive behavior.Methods:Mice were divided in different groups(n=6).Fluoxetine(5,10,15 mg/kg), (10,25,50,100 mg/kg) and melhanolic extract W.somnifera(MEWS)(10,25,50,100 mg/kg) were administered i.p.30 min.prior to the assessment of marble burying behavior and locomotor activity.The control group received vehicle of the extract.Results:Administration of aqueous extracts W.somnifera(AEWS) and MEWS(50 mg/kg) successively decreaesed the marble burying behavior activity without affecting motor activity.This effect of AEWS and MEWS was comparable to standard fluoxetine,ritanserin and parachlorophenylalanine.Conclusions:W.somnifera extract is effective in treating obsessive compulsive disorder.展开更多
Objective:To search systematically for an alternative therapy with compounds particularly from plant origin.Methods:Efficacy test of different root extracts of Withania somnifera(W. somnifera)(L) Dunal against multi d...Objective:To search systematically for an alternative therapy with compounds particularly from plant origin.Methods:Efficacy test of different root extracts of Withania somnifera(W. somnifera)(L) Dunal against multi drug resistant(MDR) Staphylococcus aureus(S.aureus) variants was performed following the agar well diffusion method.Evaluation of susceptibility pattern of the isolates was carried out by employing disk diffusion method using standard antibiotic disks. Results:In vitro study with W.somnifera root extracts was found to be effective against all the MDR S.aureus strains isolated from local and patient sources.Different root extracts of WS showed different degree of effectiveness against the isolates.Conclusions:The major active principles responsible for the antibacterial efficacy were mainly present in methanol(MeOH) extract and ethanol(EtOH) extracts as well as in butanol(BuOH) extract fraction.Amongst all the extracts the BuOH fraction was found to be most active against all the isolates but aqueous extract was the least active one.Finally it may be concluded that the antimicrobials from W.somnifera may raise an alternative therapy for MDR staphylococcal infections in near future.展开更多
Withania somnifera is highly medicinal plant species of Pakistan floristically placed in the Western Himalayan Province, Himalaya Range of Azad Jammu and Kashmir and in the Soon valley (Salt Range) of Punjab Pakistan....Withania somnifera is highly medicinal plant species of Pakistan floristically placed in the Western Himalayan Province, Himalaya Range of Azad Jammu and Kashmir and in the Soon valley (Salt Range) of Punjab Pakistan. It grows in high altitude of 5500 feet in the Himalayas. Its English name is Winter Cherry and its Urdu name is Asghand/Kutilal. It is the low lying shrub of about 1.50 m in height with erect branching. It grows in dry arid regions of Pakistan, India, China and Bangladesh. Its flowers are bisexual, small, axillary, greenish, solitary and few-flowered cymes. Chemical analysis of Ashwagandha showed that it has alkaloids and steroidal lactones (withanolides) as the main chemical constituent. W. somnifera has not yet been assessed for the IUCN Red List. However, in Pakistan, W. somnifera is falling under criteria A of endangered category. Asghand (W. somnifera) acquires much therapeutic potential which include sedative, narcotic, thyroid stimulation, anti-inflammatory, hypnotic, anti-stress, general tonic, diuretic, antimicrobial, and antitumor activities. There are number of threats responsible for the decrease of W. somnifera number in western Himalayan range and salt range of Punjab Pakistan which may include deforestation over exploitation and climatic changes. Conservation strategies need to be adopted for improving the population pool of W. somnifera. There is also the dire need to conserve this important medicinal plant species with some standard biotechnological approaches and conservation strategies in future.展开更多
The yield parameters and cost economics of Withania somnifera were studied using Integrated Nutrient Management (INM) treatments. Withania somnifera is cultivated in around 10,780 ha with a production of 8429 tones in...The yield parameters and cost economics of Withania somnifera were studied using Integrated Nutrient Management (INM) treatments. Withania somnifera is cultivated in around 10,780 ha with a production of 8429 tones in India. The annual demand of this herb increased from 7028 tones (2001-2002) to 9127 tones (2004-2005). The field experiment was conducted at the research farm of Department of Plant Physiology, College of Agriculture, Jabalpur during Kharif season of 2008-2009 (1st year) and 2009-2010 (2nd year), whereas the laboratory work was carried out in Quality Laboratory, College of Agriculture, Jabalpur. The soil of experimental field was sandy loam in texture with pH 7.5, EC 0.18 dsm-1 having good drainage. Soil analysis revealed that available nitrogen was low (202.0 kg·ha-1) whereas available phosphorus (16.25 kg·ha-1) and potassium (236.0 kg·ha-1) were in the medium range. The present paper shows how to determine the economics of varying INM treatments. Cultivation of W. somnifera in India is gaining popularity among farmers;however, due to poor soil fertility, and costly chemical fertilizers and pesticides its production is not economical or profitable.展开更多
The Rasayana plant Withania somnifera(W.somnifera)Dunal,also known as“Ashwagandha”,has been mentioned in various classical Ayurvedic texts,such as Charaka Samhita,Sushruta Samhita,and Nighantus.This Ayurvedic drug h...The Rasayana plant Withania somnifera(W.somnifera)Dunal,also known as“Ashwagandha”,has been mentioned in various classical Ayurvedic texts,such as Charaka Samhita,Sushruta Samhita,and Nighantus.This Ayurvedic drug has been referred to as a tonic that renews the body,provides physical and mental vigor in weakened states,and promotes endurance and longevity.W.somnifera possesses notable biological activity in many ailments,such as diabetes,conjunctivitis,insomnia,senile dementia,Parkinson’s disease,nervous system disorders,rheumatism,and arthritis.These pharmacological activities are due to the presence of diverse active components and their derivatives.Some lead compounds are found to be effective against anxiety and other central nervous system disorders.W.somnifera has been proven to be effective and safe for a wide range of ailments from ancient to modern times.Its reported properties represent the traditional use of W.somnifera as indicated in the literature;furthermore,W.somnifera is one of the most important prescribed drugs in Ayurveda for its multimodal effects.This current review highlights the bioactive present and provides an overview of the toxicological and pharmacological studies on W.somnifera,including preclinical and clinical studies.From its earliest utilization to its current application,W.somnifera has been recognized to be effective at clinical levels for human health and welfare.Greater attention to the safety and efficacy of W.somnifera would provide more scientific evidence,promoting global acceptance of the Ayurvedic plant.展开更多
Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the development of rigidity, resting tremors and postural instability. Recently, the focus of PD’s treatment has shifted towards herbal medic...Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the development of rigidity, resting tremors and postural instability. Recently, the focus of PD’s treatment has shifted towards herbal medicines. Mucuna pruriens (Mp) and Withania somnifera (Ws) are traditional herbal medicines known to have neuro-protective effects due to the L-DOPA present in Mp seed powder and withanoloides present in Ws root extract. Here, the synergistic effect of Mp and Ws in Parkinsonian mice induced by chronic exposure to paraquat was evaluated. Co-treatment with Mp and Ws for 9 weeks, significantly decreased the elevated nitrite levels and lipid peroxidation found in Parkinsonian mice. In behavioural tests, Mp and Ws treated mice showed a significant decrease in the time taken to cross a narrow beam, an increase in the time of stay on drum in rotarod test and an improvement in the hanging time. Furthermore, it was found that the use of Mp and Ws considerably improved the tyrosine hydroxylase expression in the substantianigra region of the brain. The results suggest that Mp and Ws may provide a platform for future drug discoveries and novel treatment strategies for PD.展开更多
Various important medicines make use of secondary metabolites that are produced by plants.Medicinal plants,such as Withania somnifera and Tinospora cordifolia,are rich sources of chemically active compounds and are re...Various important medicines make use of secondary metabolites that are produced by plants.Medicinal plants,such as Withania somnifera and Tinospora cordifolia,are rich sources of chemically active compounds and are reported to have numerous therapeutic applications.The therapeutic use of medicinal plants is widely mentioned in Ayurveda and has folkloric importance in different parts of the world.The aim of this review is to summarize the phytochemical profiles,folkloric importance,and primary pharmacological activity of W.somnifera and T.cordifolia with emphasis on their action against the novel coronavirus.展开更多
Spectral fluorescence signature, Gas Chromatography-Mass Spectrometry and Liquid Chromatography-Mass Spectrometry for identification of chemical and bioactive compounds were applied to study the plant extracts of <...Spectral fluorescence signature, Gas Chromatography-Mass Spectrometry and Liquid Chromatography-Mass Spectrometry for identification of chemical and bioactive compounds were applied to study the plant extracts of <em>Withania somnifera</em>, <em>Centella asiatica </em>and <em>Bacopa monnieri </em>which are related to the possible treatment of mental diseases as Alzheimer, Parkinson and Depression. These plants are known for different positive phytotherapeutic effects on the human brain without negative post-, adverse or after effects to the treated individuals, and have been recommended in several medical studies. Therefore, we selected these plants for further analysis, based on the inhibition results of <em>in vitro</em> Amyloid Beta fibrillation tests made by previous measurements. With this study a first screening of the complex plant extract mixtures was performed, to get an initial overview about known and unknown ingredients. In all three plants, similar main compounds were identified, however in different quality and quantity. These may provide substantial information on which compound combinations might be mainly responsible for the positive effects and should be further investigated being responsible for reducing the fibrillation process of Amyloid Beta.展开更多
Background:Withania somnifera(WS)is proposed as one of the alternatives instead of the antibiotic.This study is aimed to evaluate the inhibitory potency of enzymatic extract of the fruits of the WS.Methods:As an invit...Background:Withania somnifera(WS)is proposed as one of the alternatives instead of the antibiotic.This study is aimed to evaluate the inhibitory potency of enzymatic extract of the fruits of the WS.Methods:As an invitro experimental study,the growth rate of Shigella dysenteriae,Salmonella typhimurium,and Escherichia coli inoculated in different concentrations(25%,12.5%,6.25%and 3.125%)of the extract were assessed.A microtitre plate method was conducted.ANOVA was applied to identify statistical differences with p-value<0.05.Results:Different concentrations of extract,in comparison with control,declined the growth rate of all tested bacteria.All concentrations inhibited the growth of S.typhimurium(p<0.05).Compared to the microorganism control,effective concentration of the extract inhibiting the growth of E.coli was 12.5%,and 6.25%,while it was 12.5%,and 6.25%for Sh.dysenteriae(p<0.05).A dose-dependent response of E.coli was observed.The antibacterial activity of the extract tested was found mainly against E.coli and Sh.dysenteriae.The most resistant microorganism compared to E.coli and Sh.dysenteriae was S.typhimurium(p<0.05).25%of the concentration of the extract showed the different inhibitory effect among three tested bacteria(p<0.05).Conclusions:The extract was labeled as an antibacterial agent against the representative of three foodborne bacteria,Invitro.The common effective concentrations of the extract(12.5,and 6.25%)is recommended for further research,as food additive,to remedy digestive ailments related to E.coli,S.typhimurium and Sh.dysenteriae.展开更多
The use of medicinal plants in South Africa is cultural. Withania somnifera is one of the medicinal plants used to treat various ailments in the country. The plant species has been used by traditional medicine practit...The use of medicinal plants in South Africa is cultural. Withania somnifera is one of the medicinal plants used to treat various ailments in the country. The plant species has been used by traditional medicine practitioners to treat inflammation and painful conditions like rheumatism. It is also known to be used as a sedative and hypnotic drug. Despite the claims, there is no information in literature to corroborate the therapeutic success of Withania somnifera in the treatment of inflammation and insomnia. The study, therefore, investigated the anti-inflammatory and central nervous system depressant activities of the leaf aqueous extract of the plant species in mice and rats. Fresh leaves of W. somnifera were collected from Kirstenbosch Botanical Gardens, South Africa, authenticated by a taxonomist and a voucher specimen （UWC 005） deposited in the University＇s Herbarium. Leaf aqueous extract was prepared using standard extraction methods. The carrageenan-induced rat paw oedema test was used to determine the anti-inflammatory effects while pentobarbitone-induced sleep and locomotor activity tests were used to evaluate the sedative effect of the plant species. Phytochemical qualitative analysis, acute toxicity and HPLC studies of the plant species were also carried out using standard methods. The phytochemical qualitative analysis carried out on the dried powdered leaves of W. somnifera showed the presence of saponins, tannins and triterpene steroids. Leaf aqueous extract of IV. somnifera （100-200 mg/kg IP） significantly prolonged pentobarbitone （40 mg/kg, i.p.）-induced sleep in mice in a dose dependant manner. Diazepam （0.5 mg/kg, i.p.） significantly prolonged pentobarbitone （40 mg/kg, i.p.）-induced sleep in mice. The doses of 100 and 200 mg/kg （i.p.） of the plant species and 0.5 mg/kg （i.p.） of diazepam significantly reduced the locomotor activity of mice. Leaf aqueous extract of the plant species （50-200 mg/kg, i.p.） significantly reduced the oedema produced by carrageenan （1%） in rats over 90 min period of testing. Indomethacin （20 mg/kg, i.p.） significantly reduced carrageenan （1%）-induced oedema in rats over 120 min period of testing. The LDs0 value obtained for the leaf aqueous extract of the plant species following inter-peritoneal injection was 1,600 mg/kg while that following oral administration was probably over 4,000 mg/kg. The HPLC finger-print of the aqueous extract showed distinct peaks at the following retention times 2.977, 3.594, 4.154, 4.406, 4.660 and 15.267 min. The results obtained show that leaf aqueous extract of W. somnifera has both sedative and anti-inflammatory effects.展开更多
文摘Withania somnifera(L.)Dunal(WS),or Ashwagandha,is used clinically against arthritis,anxiety and insomnia etc,however,its potential in aquafeeds is largely unexplored.We investigated the stress-alleviation and hepatoprotective mechanisms of dietary WS supplementation in adult female darkbarbel catfish.Fish were fed with WS dietary for 5 weeks,subjected to a physical stressor(saline injection),and sampled.Brain were processed for RNA-seq to identify differentially expressed genes(DEGs)linked to stress;serum were assayed for stress-and immune-related biochemical markers;livers were examined for lipid content(Oil Red O staining)and proliferation(PCNA immunos-taining).Network pharmacology were employed to construct a"compound-target"net-work:The bioactive compounds of WS were retrieved from ChEBI and PCIDB,probable targets predicted via Swiss Target Prediction,and the“WS-ingredient-target”regulatory network was constructed using Cytoscape;key ligand-protein interactions were validated by molecular docking.Findings were replicated in juvenile fish and in SG3 cells challenged with Withanolide A.Physical stress evoked 1451 DEGs in control brains,whereas WS-supplemented reduced this to 397,indicating marked mitigation of the oxid-ative-and immune-stress response.Network pharmacology and molecular docking pre-dicted that 13 bioactive compounds in WS,especially Withanolide A and Withanolide J,can interact with targets such as MAPK8,CRHR1,NR3C2,and IARS1,being associated with stress and liver function regulation respectively.Moreover,it was proved that Withanolide A could significantly modulate stress response in juveniles and enhanced pro-liferation potency of SG3 cells.Intriguingly,in theadult female darkbarbel catfish,dietary WS lowered serum cortisol,glucose,ROS,TNF-α,and IL-6(P<0.05),up-regulated hepatocyte PCNA expression,and allievated stress-induced liver injury.These findings provide novel insights and vital basis for elucidating the mechanisms whereby herbs,including WS act in stress-relief and hepatoprotection in darkbarbel catfish.And provide a framework for advancing traditional Chinese medicine(TCM)applications in aquaculture.
文摘Aim: To determine the effect of a methanolic extract of Withania somnifera (L.) Dunal roots on sexual competence of male rats. Methods: Male rats were orally administered 3000 mg'kg^1.day^1 of root extract for 7 days. Their sexual behaviour was evaluated 7 days prior to treatment, day 3 and 7 of treatment, and day 7, 14 and 30 posttreatment by pairing each male with a receptive female. Results: The root extract induced a marked impairment in libido, sexual performance, sexual vigour, and penile erectile dysfunction. These effects were partly reversible on cessation of treatment. These antimasculine effects are not due to changes in testosterone levels or toxicity but may be attributed to hyperprolactinemic, GABAergic, serotonergic or sedative activities of the extract. Conclusion: Use of W. somnifera roots may be detrimental to male sexual competence. (Asian J Androl 2002 Dec;4: 295-298)
文摘Stroke management exerts insurmountable societal and economic burden on the patient as well as their caregivers. In the year 2010 alone, the direct and indirect costs of stroke care amounted to 36.5 billion dollars （Go et al., 2014）. Despite concentrated efforts to develop a safe, effective drug for stroke, we have not discovered one since the introduction of recombinant tissue plasminogen activator （rtPA）--the standalone FDA-approved therapy for stroke. While rtPA is highly effective, it needs to be given within 3-4.5 hours of the onset of stroke symptoms （Zivin, 2009）. This is often complicated by the delay in the commencement of treatment due to preliminary inclusion parameters that are required to be ascertained before rtPA administration.
文摘Objective:To study the influence of methanolic and aqueous extract of Withania somnifera (W.somnifera) root on the marble-burying behavior of mice a well-accepted model of obsessive compulsive behavior.Methods:Mice were divided in different groups(n=6).Fluoxetine(5,10,15 mg/kg), (10,25,50,100 mg/kg) and melhanolic extract W.somnifera(MEWS)(10,25,50,100 mg/kg) were administered i.p.30 min.prior to the assessment of marble burying behavior and locomotor activity.The control group received vehicle of the extract.Results:Administration of aqueous extracts W.somnifera(AEWS) and MEWS(50 mg/kg) successively decreaesed the marble burying behavior activity without affecting motor activity.This effect of AEWS and MEWS was comparable to standard fluoxetine,ritanserin and parachlorophenylalanine.Conclusions:W.somnifera extract is effective in treating obsessive compulsive disorder.
文摘Objective:To search systematically for an alternative therapy with compounds particularly from plant origin.Methods:Efficacy test of different root extracts of Withania somnifera(W. somnifera)(L) Dunal against multi drug resistant(MDR) Staphylococcus aureus(S.aureus) variants was performed following the agar well diffusion method.Evaluation of susceptibility pattern of the isolates was carried out by employing disk diffusion method using standard antibiotic disks. Results:In vitro study with W.somnifera root extracts was found to be effective against all the MDR S.aureus strains isolated from local and patient sources.Different root extracts of WS showed different degree of effectiveness against the isolates.Conclusions:The major active principles responsible for the antibacterial efficacy were mainly present in methanol(MeOH) extract and ethanol(EtOH) extracts as well as in butanol(BuOH) extract fraction.Amongst all the extracts the BuOH fraction was found to be most active against all the isolates but aqueous extract was the least active one.Finally it may be concluded that the antimicrobials from W.somnifera may raise an alternative therapy for MDR staphylococcal infections in near future.
文摘Withania somnifera is highly medicinal plant species of Pakistan floristically placed in the Western Himalayan Province, Himalaya Range of Azad Jammu and Kashmir and in the Soon valley (Salt Range) of Punjab Pakistan. It grows in high altitude of 5500 feet in the Himalayas. Its English name is Winter Cherry and its Urdu name is Asghand/Kutilal. It is the low lying shrub of about 1.50 m in height with erect branching. It grows in dry arid regions of Pakistan, India, China and Bangladesh. Its flowers are bisexual, small, axillary, greenish, solitary and few-flowered cymes. Chemical analysis of Ashwagandha showed that it has alkaloids and steroidal lactones (withanolides) as the main chemical constituent. W. somnifera has not yet been assessed for the IUCN Red List. However, in Pakistan, W. somnifera is falling under criteria A of endangered category. Asghand (W. somnifera) acquires much therapeutic potential which include sedative, narcotic, thyroid stimulation, anti-inflammatory, hypnotic, anti-stress, general tonic, diuretic, antimicrobial, and antitumor activities. There are number of threats responsible for the decrease of W. somnifera number in western Himalayan range and salt range of Punjab Pakistan which may include deforestation over exploitation and climatic changes. Conservation strategies need to be adopted for improving the population pool of W. somnifera. There is also the dire need to conserve this important medicinal plant species with some standard biotechnological approaches and conservation strategies in future.
文摘The yield parameters and cost economics of Withania somnifera were studied using Integrated Nutrient Management (INM) treatments. Withania somnifera is cultivated in around 10,780 ha with a production of 8429 tones in India. The annual demand of this herb increased from 7028 tones (2001-2002) to 9127 tones (2004-2005). The field experiment was conducted at the research farm of Department of Plant Physiology, College of Agriculture, Jabalpur during Kharif season of 2008-2009 (1st year) and 2009-2010 (2nd year), whereas the laboratory work was carried out in Quality Laboratory, College of Agriculture, Jabalpur. The soil of experimental field was sandy loam in texture with pH 7.5, EC 0.18 dsm-1 having good drainage. Soil analysis revealed that available nitrogen was low (202.0 kg·ha-1) whereas available phosphorus (16.25 kg·ha-1) and potassium (236.0 kg·ha-1) were in the medium range. The present paper shows how to determine the economics of varying INM treatments. Cultivation of W. somnifera in India is gaining popularity among farmers;however, due to poor soil fertility, and costly chemical fertilizers and pesticides its production is not economical or profitable.
文摘The Rasayana plant Withania somnifera(W.somnifera)Dunal,also known as“Ashwagandha”,has been mentioned in various classical Ayurvedic texts,such as Charaka Samhita,Sushruta Samhita,and Nighantus.This Ayurvedic drug has been referred to as a tonic that renews the body,provides physical and mental vigor in weakened states,and promotes endurance and longevity.W.somnifera possesses notable biological activity in many ailments,such as diabetes,conjunctivitis,insomnia,senile dementia,Parkinson’s disease,nervous system disorders,rheumatism,and arthritis.These pharmacological activities are due to the presence of diverse active components and their derivatives.Some lead compounds are found to be effective against anxiety and other central nervous system disorders.W.somnifera has been proven to be effective and safe for a wide range of ailments from ancient to modern times.Its reported properties represent the traditional use of W.somnifera as indicated in the literature;furthermore,W.somnifera is one of the most important prescribed drugs in Ayurveda for its multimodal effects.This current review highlights the bioactive present and provides an overview of the toxicological and pharmacological studies on W.somnifera,including preclinical and clinical studies.From its earliest utilization to its current application,W.somnifera has been recognized to be effective at clinical levels for human health and welfare.Greater attention to the safety and efficacy of W.somnifera would provide more scientific evidence,promoting global acceptance of the Ayurvedic plant.
文摘Parkinson’s disease (PD) is a neurodegenerative disorder characterized by the development of rigidity, resting tremors and postural instability. Recently, the focus of PD’s treatment has shifted towards herbal medicines. Mucuna pruriens (Mp) and Withania somnifera (Ws) are traditional herbal medicines known to have neuro-protective effects due to the L-DOPA present in Mp seed powder and withanoloides present in Ws root extract. Here, the synergistic effect of Mp and Ws in Parkinsonian mice induced by chronic exposure to paraquat was evaluated. Co-treatment with Mp and Ws for 9 weeks, significantly decreased the elevated nitrite levels and lipid peroxidation found in Parkinsonian mice. In behavioural tests, Mp and Ws treated mice showed a significant decrease in the time taken to cross a narrow beam, an increase in the time of stay on drum in rotarod test and an improvement in the hanging time. Furthermore, it was found that the use of Mp and Ws considerably improved the tyrosine hydroxylase expression in the substantianigra region of the brain. The results suggest that Mp and Ws may provide a platform for future drug discoveries and novel treatment strategies for PD.
文摘Various important medicines make use of secondary metabolites that are produced by plants.Medicinal plants,such as Withania somnifera and Tinospora cordifolia,are rich sources of chemically active compounds and are reported to have numerous therapeutic applications.The therapeutic use of medicinal plants is widely mentioned in Ayurveda and has folkloric importance in different parts of the world.The aim of this review is to summarize the phytochemical profiles,folkloric importance,and primary pharmacological activity of W.somnifera and T.cordifolia with emphasis on their action against the novel coronavirus.
文摘Spectral fluorescence signature, Gas Chromatography-Mass Spectrometry and Liquid Chromatography-Mass Spectrometry for identification of chemical and bioactive compounds were applied to study the plant extracts of <em>Withania somnifera</em>, <em>Centella asiatica </em>and <em>Bacopa monnieri </em>which are related to the possible treatment of mental diseases as Alzheimer, Parkinson and Depression. These plants are known for different positive phytotherapeutic effects on the human brain without negative post-, adverse or after effects to the treated individuals, and have been recommended in several medical studies. Therefore, we selected these plants for further analysis, based on the inhibition results of <em>in vitro</em> Amyloid Beta fibrillation tests made by previous measurements. With this study a first screening of the complex plant extract mixtures was performed, to get an initial overview about known and unknown ingredients. In all three plants, similar main compounds were identified, however in different quality and quantity. These may provide substantial information on which compound combinations might be mainly responsible for the positive effects and should be further investigated being responsible for reducing the fibrillation process of Amyloid Beta.
文摘Background:Withania somnifera(WS)is proposed as one of the alternatives instead of the antibiotic.This study is aimed to evaluate the inhibitory potency of enzymatic extract of the fruits of the WS.Methods:As an invitro experimental study,the growth rate of Shigella dysenteriae,Salmonella typhimurium,and Escherichia coli inoculated in different concentrations(25%,12.5%,6.25%and 3.125%)of the extract were assessed.A microtitre plate method was conducted.ANOVA was applied to identify statistical differences with p-value<0.05.Results:Different concentrations of extract,in comparison with control,declined the growth rate of all tested bacteria.All concentrations inhibited the growth of S.typhimurium(p<0.05).Compared to the microorganism control,effective concentration of the extract inhibiting the growth of E.coli was 12.5%,and 6.25%,while it was 12.5%,and 6.25%for Sh.dysenteriae(p<0.05).A dose-dependent response of E.coli was observed.The antibacterial activity of the extract tested was found mainly against E.coli and Sh.dysenteriae.The most resistant microorganism compared to E.coli and Sh.dysenteriae was S.typhimurium(p<0.05).25%of the concentration of the extract showed the different inhibitory effect among three tested bacteria(p<0.05).Conclusions:The extract was labeled as an antibacterial agent against the representative of three foodborne bacteria,Invitro.The common effective concentrations of the extract(12.5,and 6.25%)is recommended for further research,as food additive,to remedy digestive ailments related to E.coli,S.typhimurium and Sh.dysenteriae.
文摘The use of medicinal plants in South Africa is cultural. Withania somnifera is one of the medicinal plants used to treat various ailments in the country. The plant species has been used by traditional medicine practitioners to treat inflammation and painful conditions like rheumatism. It is also known to be used as a sedative and hypnotic drug. Despite the claims, there is no information in literature to corroborate the therapeutic success of Withania somnifera in the treatment of inflammation and insomnia. The study, therefore, investigated the anti-inflammatory and central nervous system depressant activities of the leaf aqueous extract of the plant species in mice and rats. Fresh leaves of W. somnifera were collected from Kirstenbosch Botanical Gardens, South Africa, authenticated by a taxonomist and a voucher specimen （UWC 005） deposited in the University＇s Herbarium. Leaf aqueous extract was prepared using standard extraction methods. The carrageenan-induced rat paw oedema test was used to determine the anti-inflammatory effects while pentobarbitone-induced sleep and locomotor activity tests were used to evaluate the sedative effect of the plant species. Phytochemical qualitative analysis, acute toxicity and HPLC studies of the plant species were also carried out using standard methods. The phytochemical qualitative analysis carried out on the dried powdered leaves of W. somnifera showed the presence of saponins, tannins and triterpene steroids. Leaf aqueous extract of IV. somnifera （100-200 mg/kg IP） significantly prolonged pentobarbitone （40 mg/kg, i.p.）-induced sleep in mice in a dose dependant manner. Diazepam （0.5 mg/kg, i.p.） significantly prolonged pentobarbitone （40 mg/kg, i.p.）-induced sleep in mice. The doses of 100 and 200 mg/kg （i.p.） of the plant species and 0.5 mg/kg （i.p.） of diazepam significantly reduced the locomotor activity of mice. Leaf aqueous extract of the plant species （50-200 mg/kg, i.p.） significantly reduced the oedema produced by carrageenan （1%） in rats over 90 min period of testing. Indomethacin （20 mg/kg, i.p.） significantly reduced carrageenan （1%）-induced oedema in rats over 120 min period of testing. The LDs0 value obtained for the leaf aqueous extract of the plant species following inter-peritoneal injection was 1,600 mg/kg while that following oral administration was probably over 4,000 mg/kg. The HPLC finger-print of the aqueous extract showed distinct peaks at the following retention times 2.977, 3.594, 4.154, 4.406, 4.660 and 15.267 min. The results obtained show that leaf aqueous extract of W. somnifera has both sedative and anti-inflammatory effects.
